Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Treatments for hair loss focus on targeting the immune system.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Upadacitinib improved multiple immune-related conditions in one patient.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Exosomes show promise for diagnosing and treating skin conditions and hair loss.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Hidradenitis suppurativa is a skin condition possibly caused by hair follicle issues, with treatments focusing on infection and inflammation.

Immune cells affect hair growth and could lead to new hair loss treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

New treatments focusing on immune pathways show promise for stubborn hair loss.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.